World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
11509
World Ranking
4044
National Ranking
171

Marc Pellegrini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marc Pellegrini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 138 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marc Pellegrini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marc Pellegrini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marc Pellegrini is affiliated with the Walter and Eliza Hall Institute of Medical Research in Australia. Their research spans multiple disciplines primarily within medicine, immunology, microbiology, and molecular biology.

The main fields of study for Pellegrini include:

  • Medicine
  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology

Subfields of their work further focus on:

  • Immunology
  • Infectious Diseases
  • Molecular Biology
  • Epidemiology
  • Oncology

Their research topics cover a range of immunological and infectious disease themes with a significant emphasis on SARS-CoV-2 and COVID-19. Key topics include:

  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Cell death mechanisms and regulation
  • Inflammasome and immune disorders
  • Immune Cell Function and Interaction
  • interferon and immune responses
  • COVID-19 Clinical Research Studies

Pellegrini has published extensively in several journals. Frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Immunity
  • Nature Communications
  • Cell Death and Disease
  • The EMBO Journal

Notable recent papers authored with Pellegrini's involvement are:

  • "Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2" (2020), The EMBO Journal
  • "Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice" (2021), Proceedings of the National Academy of Sciences
  • "Flexible Usage and Interconnectivity of Diverse Cell Death Pathways Protect against Intracellular Infection" (2020), Immunity
  • "Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway" (2022), Immunity
  • "Effector and stem-like memory cell fates are imprinted in distinct lymph node niches directed by CXCR3 ligands" (2021), Nature Immunology

The scientist has collaborated frequently with a number of colleagues in their field. Regular co-authors include:

  • Marcel Doerflinger
  • James P. Cooney
  • Cody C. Allison
  • Liana Mackiewicz
  • Stefanie M. Bader

Best Publications

  • Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes.

    Laura K. Mackay;Laura K. Mackay;Martina Minnich;Natasja A. M. Kragten;Yang Liao;Yang Liao

  • BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes.

    Philippe Bouillet;Jared F. Purton;Dale I. Godfrey;Li-Chen Zhang

  • FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal

    Han You;Marc Pellegrini;Marc Pellegrini;Katsuya Tsuchihara;Katsuya Tsuchihara;Kazuo Yamamoto;Kazuo Yamamoto

  • Transcription factor IRF4 Promotes CD8 + T cell exhaustion and limits the development of memory-like T cells during chronic infection

    Kevin Man;Sarah S. Gabriel;Yang Liao;Yang Liao;Renee Gloury;Renee Gloury

  • CXCR5 + follicular cytotoxic T cells control viral infection in B cell follicles

    Yew Ann Leong;Yaping Chen;Hong Sheng Ong;Di Wu

  • Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.

    Theresa Klemm;Gregor Ebert;Dale J Calleja;Cody C Allison

  • The transcription factor IRF4 is essential for TCR affinity–mediated metabolic programming and clonal expansion of T cells

    Kevin Man;Maria Miasari;Maria Miasari;Wei Shi;Wei Shi;Annie Xin;Annie Xin

  • IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology

    Marc Pellegrini;Thomas Calzascia;Jesse G. Toe;Simon P. Preston

  • NLRP1 Inflammasome Activation Induces Pyroptosis of Hematopoietic Progenitor Cells

    Seth L. Masters;Motti Gerlic;Motti Gerlic;Donald Metcalf;Donald Metcalf;Simon Preston;Simon Preston

  • TNF-α is critical for antitumor but not antiviral T cell immunity in mice

    Thomas Calzascia;Marc Pellegrini;Håkan Hall;Laurent Sabbagh;Laurent Sabbagh

  • Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim

    Marc Pellegrini;Gabrielle Belz;Philippe Bouillet;Andreas Strasser

  • Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies

    Marc Pellegrini;Thomas Calzascia;Thomas Calzascia;Alisha R Elford;Arda Shahinian

  • Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma

    Ralph K Lindemann;Andrea Newbold;K F Whitecross;Leonie A Cluse

  • T-lymphocyte death during shutdown of an immune response

    Andreas Strasser;Marc Pellegrini

  • Severe Malaria Infections Impair Germinal Center Responses by Inhibiting T Follicular Helper Cell Differentiation

    Victoria Ryg-Cornejo;Victoria Ryg-Cornejo;Lisa Julia Ioannidis;Lisa Julia Ioannidis;Ann Ly;Ann Ly;Chris Yu Chiu;Chris Yu Chiu

  • Role of PI3K/Akt signaling in memory CD8 T cell differentiation

    Eui Ho Kim;M. Suresh

  • A molecular threshold for effector CD8+ T cell differentiation controlled by transcription factors Blimp-1 and T-bet

    Annie Xin;Frederick Masson;Frederick Masson;Frederick Masson;Yang Liao;Yang Liao;Simon Peter Preston;Simon Peter Preston

  • CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity

    Thomas Calzascia;Marc Pellegrini;Albert Lin;Kristine M. Garza

  • Loss of Bim Increases T Cell Production and Function in Interleukin 7 Receptor–deficient Mice

    Marc Pellegrini;Philippe Bouillet;Mikara Robati;Gabrielle T. Belz

  • Fatal Hepatitis Mediated by Tumor Necrosis Factor TNFα Requires Caspase-8 and Involves the BH3-Only Proteins Bid and Bim

    Thomas Kaufmann;Philipp J. Jost;Marc Pellegrini;Hamsa Puthalakath

  • Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice.

    Phillip Pymm;Phillip Pymm;Amy Adair;Li-Jin Chan;Li-Jin Chan;James P Cooney;James P Cooney

Frequent Co-Authors

Gabrielle T. Belz
Gabrielle T. Belz University of Queensland
Andreas Strasser
Andreas Strasser Walter and Eliza Hall Institute of Medical Research
Pamela S. Ohashi
Pamela S. Ohashi Princess Margaret Cancer Centre
John Silke
John Silke Walter and Eliza Hall Institute of Medical Research
Axel Kallies
Axel Kallies University of Melbourne
Tak W. Mak
Tak W. Mak Princess Margaret Cancer Centre
Gordon K. Smyth
Gordon K. Smyth Walter and Eliza Hall Institute of Medical Research
Stephen L. Nutt
Stephen L. Nutt Walter and Eliza Hall Institute of Medical Research
Donald Metcalf
Donald Metcalf Walter and Eliza Hall Institute of Medical Research
Philippe Bouillet
Philippe Bouillet Walter and Eliza Hall Institute of Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Many professionals choose to advance their qualifications through accelerated programs that allow faster entry into the workforce. For instance, accelerated NP programs provide a streamlined path for registered nurses aiming to become nurse practitioners with specialized clinical expertise.

Individuals without a nursing background can also enter the field efficiently. Options such as online RN programs for non nurses in Florida offer accessible routes for career changers to earn nursing credentials while balancing other commitments.

Those seeking an easier entry into nursing roles might consider easiest accelerated nursing programs, which focus on reducing barriers to admission and provide an expedited curriculum. Similarly, lpn schools easy to get into serve as practical starting points for aspiring licensed practical nurses, offering quicker credentialing and hands-on healthcare experience.

Understanding these educational pathways is crucial for tailoring your career in Immunology, whether you aim to work in clinical settings, research labs, or specialized nursing roles. These programs foster interdisciplinary skills essential for tackling immunological challenges within the healthcare system.

Best Scientists Citing Marc Pellegrini

Trending Scientists

Recently Published Articles